Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
StoneCo combination with Linx
Davis Polk is advising StoneCo Ltd. on its agreement for STNE Participações S.A., a controlled company of Stone that holds…
ServiceNow $1.5 billion notes offering
Davis Polk advised the representatives of the several underwriters in connection with a debut SEC-registered bond offering…
Freeline Therapeutics Holdings $158.8 million IPO
Davis Polk advised Freeline Therapeutics Holdings plc on its $158.8 million initial public offering of 8,823,529 American…
Bloom Energy $200 million green convertible senior notes offering
Davis Polk advised the initial purchaser in connection with a Rule 144A offering by Bloom Energy Corporation of $200…
ServiceNow $1.5 billion notes offering
Davis Polk advised the representatives of the several underwriters in connection with a debut SEC-registered bond offering…
ServiceNow $1.5 billion notes offering
Davis Polk advised the representatives of the several underwriters in connection with a debut SEC-registered bond offering…
Freeline Therapeutics Holdings $158.8 million IPO
Davis Polk advised Freeline Therapeutics Holdings plc on its $158.8 million initial public offering of 8,823,529 American…
Tigermed HK$10.7 billion IPO and Hong Kong listing
Davis Polk advised Hangzhou Tigermed Consulting Co., Ltd. in connection with its initial public offering and listing on the…
Linde $1 billion notes offering
Davis Polk advised the underwriters on the registered offering of $700 million aggregate principal amount of 1.100% notes…
Turning Point Therapeutics $250 million at-the-market offering
Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Turning Point Therapeutics, Inc. of its…